Geraets Chris N W, Wallinius Märta, Sygel Kristina
Lund Clinical Research on Externalizing and Developmental Psychopathology, Child and Adolescent Psychiatry, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
Research and Development Unit, Regional Forensic Psychiatric Clinic, Växjö, Sweden.
Front Psychiatry. 2022 Feb 28;13:828410. doi: 10.3389/fpsyt.2022.828410. eCollection 2022.
Technological developments such as Virtual reality (VR) provide new opportunities to extend and innovate mental healthcare. VR as a tool for clinical assessment has been described as promising, as it can enable real-time assessment within real-like environments or contexts as opposed to self-report and behavioral tasks in laboratory settings.
With this systematic review we aimed to provide an overview of recent studies using VR in the assessment of psychiatric disorders.
A systematic search was performed using Pubmed, Embase, PsycInfo, and Web of Science between 2016 and 2020. Studies were included if they used immersive VR, concerned assessment of psychiatric symptoms/disorders, and included adult patients with psychiatric disorders.
The search resulted in 3,163 potentially eligible articles, from which a total of 27 studies fulfilled inclusion criteria. Most studies considered anxiety ( = 7), addictive, ( = 7), or psychotic disorders ( = 5). Regarding ADHD ( = 3), PTSD ( = 3), and pedophilic disorder ( = 1), a few studies had been performed since 2016. The majority of the included studies compared patient groups to healthy control groups.
Recent studies on VR-assisted psychiatric assessments have been conducted to validate VR environments, to assess symptoms for diagnostics or therapy goals, search for biomarkers, and to gain knowledge on psychiatric disorders. VR tasks were able to detect some difference between patient and healthy control groups, mainly with regard to self-report measures. Despite previous, promising prospects, the use of VR as a tool in clinical assessments must still be considered as a field in need of continued developments and evaluations.
www.crd.york.ac.uk/prospero, identifier: CRD42021233772.
虚拟现实（VR）等技术发展为精神卫生保健的拓展和创新提供了新机遇。VR作为一种临床评估工具已被描述为具有前景，因为它能够在逼真的环境或情境中进行实时评估，这与实验室环境中的自我报告和行为任务不同。
通过本系统评价，我们旨在概述近期使用VR评估精神障碍的研究。
2016年至2020年间，使用PubMed、Embase、PsycInfo和Web of Science进行了系统检索。纳入的研究需使用沉浸式VR、涉及精神症状/障碍的评估，并包括患有精神障碍的成年患者。
检索结果为3163篇可能符合条件的文章，其中共有27项研究符合纳入标准。大多数研究关注焦虑症（n = 7）、成瘾性疾病（n = 7）或精神障碍（n = 5）。关于注意力缺陷多动障碍（n = 3）、创伤后应激障碍（n = 3）和恋童癖障碍（n = 1），自2016年以来进行了一些研究。大多数纳入研究将患者组与健康对照组进行了比较。
近期关于VR辅助精神评估的研究旨在验证VR环境、评估用于诊断或治疗目标的症状、寻找生物标志物以及了解精神障碍。VR任务能够检测出患者组与健康对照组之间的一些差异，主要在自我报告测量方面。尽管此前有前景，但将VR用作临床评估工具仍必须被视为一个需要持续发展和评估的领域。
